Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MTX110 |
Synonyms | |
Therapy Description |
MTX110 is a nanoparticle formulation of Panobinostat which can be delivered into the brain via convection-enhanced delivery (PMID: 29856296, PMID: 32357333). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MTX110 | MTX-110|MTX 110 | MTX110 is a nanoparticle formulation of Panobinostat which can be delivered into the brain via convection-enhanced delivery (PMID: 29856296, PMID: 32357333). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03566199 | Phase Ib/II | MTX110 | MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (PNOC015) | Completed | USA | 0 |
NCT04315064 | Phase I | MTX110 | Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults With Recurrent Medulloblastoma | Recruiting | USA | 0 |
NCT05324501 | Phase I | MTX110 Lomustine + MTX110 | A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma (MAGIC-G1) | Active, not recruiting | USA | 0 |
NCT04264143 | Phase I | MTX110 | CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas | Completed | USA | 0 |